1. Amphetamine designer drugs – an overview and epidemiology;Christophersen;Toxicol. Lett.,2000
2. Drug Enforcement Agency. 2020 National Drug Threat Assessment (NDTA) [Internet]. 2021 Mar [cited 2023 Oct 03]; p. 100. Available from: https://www.dea.gov/sites/default/files/2021-02/DIR-008-21%202020%20National%20Drug%20Threat%20Assessment_WEB.pdf.
3. Sprague, J.E. Riley, C..L. Mills, E.M. Chapter 36 Body temperature regulation and drugs of abuse. Handb Clin Neurol. 157 (2018) 623–63DOI:10.1016/B978-0-444-64074-1.00036-7.
4. European Monitoring Centre for Drugs and Drug Addiction, Europol. EMCDDA–Europol Joint Report on a new psychoactive substance: (4-MA) 4-methylamphetamine | www.emcdda.europa.eu [Internet]. Luxembourg: Publications Office of the European Union; 2012 [cited 2023 Oct 2]. Available from: https://www.emcdda.europa.eu/publications/joint-reports/4-ma_en.
5. 4-methyl-amphetamine: a health threat for recreational amphetamine users;van Blanckaert;J. Psychopharmacol.,2013